Gary L. Kunz

Array ( [id] => 3589178 [patent_doc_number] => 05552538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Oligonucleotides with cleavable sites' [patent_app_type] => 1 [patent_app_number] => 8/437581 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7079 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552538.pdf [firstpage_image] =>[orig_patent_app_number] => 437581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3512224 [patent_doc_number] => 05563257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Phospholipid derivatives of nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/438240 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3679 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563257.pdf [firstpage_image] =>[orig_patent_app_number] => 438240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3548976 [patent_doc_number] => 05545730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Multifunctional nucleic acid monomer' [patent_app_type] => 1 [patent_app_number] => 8/436125 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7080 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545730.pdf [firstpage_image] =>[orig_patent_app_number] => 436125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604669 [patent_doc_number] => 05578717 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Nucleotides for introducing selectably cleavable and/or abasic sites into oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/436663 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7056 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578717.pdf [firstpage_image] =>[orig_patent_app_number] => 436663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726080 [patent_doc_number] => 05681943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Method for covalently linking adjacent oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/436145 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 6893 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681943.pdf [firstpage_image] =>[orig_patent_app_number] => 436145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625272 [patent_doc_number] => 05602244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Polynucleotide phosphorodithioate compounds' [patent_app_type] => 1 [patent_app_number] => 8/436714 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16886 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602244.pdf [firstpage_image] =>[orig_patent_app_number] => 436714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636310 [patent_doc_number] => 05631360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'N-phthaloyl-protected 2\'-amino-nucleoside phosphoramdites' [patent_app_type] => 1 [patent_app_number] => 8/435232 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11982 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631360.pdf [firstpage_image] =>[orig_patent_app_number] => 435232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880178 [patent_doc_number] => 05804683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Deprotection of RNA with alkylamine' [patent_app_type] => 1 [patent_app_number] => 8/435113 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 11591 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804683.pdf [firstpage_image] =>[orig_patent_app_number] => 435113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3602562 [patent_doc_number] => 05578582 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Methods of treating ischemia with C2, N.sup.6 -disubstituted adenosine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/435005 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10501 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578582.pdf [firstpage_image] =>[orig_patent_app_number] => 435005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575761 [patent_doc_number] => 06469158 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Synthesis, deprotection, analysis and purification of RNA and ribozymes' [patent_app_type] => B1 [patent_app_number] => 08/433218 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11932 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469158.pdf [firstpage_image] =>[orig_patent_app_number] => 08433218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650809 [patent_doc_number] => 05639875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Methods for H-phosphonate syntheis of oligonucleotides using triphosgene' [patent_app_type] => 1 [patent_app_number] => 8/430437 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3226 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639875.pdf [firstpage_image] =>[orig_patent_app_number] => 430437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660429 [patent_doc_number] => 05627276 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Peroxide degradation of DNA for visocity reduction' [patent_app_type] => 1 [patent_app_number] => 8/424458 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2360 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627276.pdf [firstpage_image] =>[orig_patent_app_number] => 424458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634328 [patent_doc_number] => 05631238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Spicamycin derivatives and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/429303 [patent_app_country] => US [patent_app_date] => 1995-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48998 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631238.pdf [firstpage_image] =>[orig_patent_app_number] => 429303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3898079 [patent_doc_number] => 05750673 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Nucleosides with 2\'-O-modifications' [patent_app_type] => 1 [patent_app_number] => 8/426807 [patent_app_country] => US [patent_app_date] => 1995-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10152 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750673.pdf [firstpage_image] =>[orig_patent_app_number] => 426807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588255 [patent_doc_number] => 05520899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Process for preparing boron, aluminum, and phosphorus silicates for purification of DNA' [patent_app_type] => 1 [patent_app_number] => 8/425637 [patent_app_country] => US [patent_app_date] => 1995-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4404 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/520/05520899.pdf [firstpage_image] =>[orig_patent_app_number] => 425637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3615922 [patent_doc_number] => 05510470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Chiral, bidentate organophosphorus ligand' [patent_app_type] => 1 [patent_app_number] => 8/424674 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7663 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510470.pdf [firstpage_image] =>[orig_patent_app_number] => 424674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4335378 [patent_doc_number] => 06333169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'HER2 extracellular domain' [patent_app_type] => 1 [patent_app_number] => 8/422734 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 7065 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333169.pdf [firstpage_image] =>[orig_patent_app_number] => 422734 [rel_patent_id] =>[rel_patent_doc_number] =>)